ACE MEDICINE LIMITED

Company Registration Number:
05978197 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2026

Period of accounts

Start date: 01 April 2025

End date: 31 March 2026

ACE MEDICINE LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2026

Balance sheet
Notes

ACE MEDICINE LIMITED

Balance sheet

As at 31 March 2026


Notes
2026
2025


£
£
Fixed assets
Tangible assets: 3 201,050 260,111
Total fixed assets: 201,050 260,111
Current assets
Debtors: 4 1,136,990 907,246
Cash at bank and in hand: 424,112 1,187,687
Total current assets: 1,561,102 2,094,933
Creditors: amounts falling due within one year:   (76,442) (581,302)
Net current assets (liabilities): 1,484,660 1,513,631
Total assets less current liabilities: 1,685,710 1,773,742
Total net assets (liabilities): 1,685,710 1,773,742
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 1,685,610 1,773,642
Shareholders funds: 1,685,710 1,773,742

The notes form part of these financial statements

ACE MEDICINE LIMITED

Balance sheet statements

For the year ending 31 March 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 02 July 2026
and signed on behalf of the board by:

Name: Sandeep Rattan
Status: Director

The notes form part of these financial statements

ACE MEDICINE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ACE MEDICINE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

2. Employees

2026 2025
Average number of employees during the period 2 2

ACE MEDICINE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

3. Tangible Assets

Total
Cost £
At 01 April 2025 473,643
Additions 3,804
At 31 March 2026 477,447
Depreciation
At 01 April 2025 213,532
Charge for year 62,865
At 31 March 2026 276,397
Net book value
At 31 March 2026 201,050
At 31 March 2025 260,111

ACE MEDICINE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

4. Debtors

2026 2025
££
Debtors due after more than one year: 0 0

ACE MEDICINE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

5. Related party transactions

Name of the related party: Rattan Property Ltd
Relationship:
Directors and Shareholders are same for both companies
Description of the Transaction: Loan to related party £936,642 (in the last balance sheet at 31/03/2025 £906,642)
£
Balance at 01 April 2025 906,642
Balance at 31 March 2026 936,642